Pharma & Healthcare
Global Regenerative Biologic Injectables Market Research Report 2025
- Dec 02, 25
- ID: 617960
- Pages: 78
- Figures: 78
- Views: 13
This report aims to provide a comprehensive presentation of the global market for Regenerative Biologic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Biologic Injectables.
The Regenerative Biologic Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Biologic Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regenerative Biologic Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arthrex
Stryker
Zimmer Biomet
EmCyte
Regen Lab
Applied Biologics
Smith+Nephew
Organogenesis
MiMedx
Celularity
Segment by Type
Platelet-Rich Plasma (PRP)
Autologous Cell/BMAC/Stem-Cell Derived
Amniotic/Placental Allografts
Other
Segment by Therapeutic Application
Orthopedics & MSK
Aesthetics/Anti-Aging
Wound & Ulcer Care
Other
Segment by Source of Material
Autologous
Allogeneic
Xenogeneic
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Therapeutic Application etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Biologic Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Regenerative Biologic Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Biologic Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, by Therapeutic Application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regenerative Biologic Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arthrex
Stryker
Zimmer Biomet
EmCyte
Regen Lab
Applied Biologics
Smith+Nephew
Organogenesis
MiMedx
Celularity
Segment by Type
Platelet-Rich Plasma (PRP)
Autologous Cell/BMAC/Stem-Cell Derived
Amniotic/Placental Allografts
Other
Segment by Therapeutic Application
Orthopedics & MSK
Aesthetics/Anti-Aging
Wound & Ulcer Care
Other
Segment by Source of Material
Autologous
Allogeneic
Xenogeneic
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Therapeutic Application etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Biologic Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Platelet-Rich Plasma (PRP)
1.2.3 Autologous Cell/BMAC/Stem-Cell Derived
1.2.4 Amniotic/Placental Allografts
1.2.5 Other
1.3 Market by Therapeutic Application
1.3.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application: 2020 VS 2024 VS 2031
1.3.2 Orthopedics & MSK
1.3.3 Aesthetics/Anti-Aging
1.3.4 Wound & Ulcer Care
1.3.5 Other
1.4 Market by Source of Material
1.4.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material: 2020 VS 2024 VS 2031
1.4.2 Autologous
1.4.3 Allogeneic
1.4.4 Xenogeneic
1.5 Market by Application
1.5.1 Global Regenerative Biologic Injectables Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Biologic Injectables Market Perspective (2020-2031)
2.2 Global Regenerative Biologic Injectables Growth Trends by Region
2.2.1 Global Regenerative Biologic Injectables Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regenerative Biologic Injectables Historic Market Size by Region (2020-2025)
2.2.3 Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031)
2.3 Regenerative Biologic Injectables Market Dynamics
2.3.1 Regenerative Biologic Injectables Industry Trends
2.3.2 Regenerative Biologic Injectables Market Drivers
2.3.3 Regenerative Biologic Injectables Market Challenges
2.3.4 Regenerative Biologic Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Biologic Injectables Players by Revenue
3.1.1 Global Top Regenerative Biologic Injectables Players by Revenue (2020-2025)
3.1.2 Global Regenerative Biologic Injectables Revenue Market Share by Players (2020-2025)
3.2 Global Top Regenerative Biologic Injectables Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regenerative Biologic Injectables Revenue
3.4 Global Regenerative Biologic Injectables Market Concentration Ratio
3.4.1 Global Regenerative Biologic Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Biologic Injectables Revenue in 2024
3.5 Global Key Players of Regenerative Biologic Injectables Head office and Area Served
3.6 Global Key Players of Regenerative Biologic Injectables, Product and Application
3.7 Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Biologic Injectables Breakdown Data by Type
4.1 Global Regenerative Biologic Injectables Historic Market Size by Type (2020-2025)
4.2 Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031)
5 Regenerative Biologic Injectables Breakdown Data by Application
5.1 Global Regenerative Biologic Injectables Historic Market Size by Application (2020-2025)
5.2 Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regenerative Biologic Injectables Market Size (2020-2031)
6.2 North America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regenerative Biologic Injectables Market Size by Country (2020-2025)
6.4 North America Regenerative Biologic Injectables Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regenerative Biologic Injectables Market Size (2020-2031)
7.2 Europe Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regenerative Biologic Injectables Market Size by Country (2020-2025)
7.4 Europe Regenerative Biologic Injectables Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Biologic Injectables Market Size (2020-2031)
8.2 Asia-Pacific Regenerative Biologic Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025)
8.4 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Regenerative Biologic Injectables Market Size (2020-2031)
9.2 Latin America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025)
9.4 Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Biologic Injectables Market Size (2020-2031)
10.2 Middle East & Africa Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025)
10.4 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arthrex
11.1.1 Arthrex Company Details
11.1.2 Arthrex Business Overview
11.1.3 Arthrex Regenerative Biologic Injectables Introduction
11.1.4 Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.1.5 Arthrex Recent Development
11.2 Stryker
11.2.1 Stryker Company Details
11.2.2 Stryker Business Overview
11.2.3 Stryker Regenerative Biologic Injectables Introduction
11.2.4 Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.2.5 Stryker Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Biologic Injectables Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.3.5 Zimmer Biomet Recent Development
11.4 EmCyte
11.4.1 EmCyte Company Details
11.4.2 EmCyte Business Overview
11.4.3 EmCyte Regenerative Biologic Injectables Introduction
11.4.4 EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.4.5 EmCyte Recent Development
11.5 Regen Lab
11.5.1 Regen Lab Company Details
11.5.2 Regen Lab Business Overview
11.5.3 Regen Lab Regenerative Biologic Injectables Introduction
11.5.4 Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.5.5 Regen Lab Recent Development
11.6 Applied Biologics
11.6.1 Applied Biologics Company Details
11.6.2 Applied Biologics Business Overview
11.6.3 Applied Biologics Regenerative Biologic Injectables Introduction
11.6.4 Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.6.5 Applied Biologics Recent Development
11.7 Smith+Nephew
11.7.1 Smith+Nephew Company Details
11.7.2 Smith+Nephew Business Overview
11.7.3 Smith+Nephew Regenerative Biologic Injectables Introduction
11.7.4 Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.7.5 Smith+Nephew Recent Development
11.8 Organogenesis
11.8.1 Organogenesis Company Details
11.8.2 Organogenesis Business Overview
11.8.3 Organogenesis Regenerative Biologic Injectables Introduction
11.8.4 Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.8.5 Organogenesis Recent Development
11.9 MiMedx
11.9.1 MiMedx Company Details
11.9.2 MiMedx Business Overview
11.9.3 MiMedx Regenerative Biologic Injectables Introduction
11.9.4 MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.9.5 MiMedx Recent Development
11.10 Celularity
11.10.1 Celularity Company Details
11.10.2 Celularity Business Overview
11.10.3 Celularity Regenerative Biologic Injectables Introduction
11.10.4 Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.10.5 Celularity Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Platelet-Rich Plasma (PRP)
1.2.3 Autologous Cell/BMAC/Stem-Cell Derived
1.2.4 Amniotic/Placental Allografts
1.2.5 Other
1.3 Market by Therapeutic Application
1.3.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application: 2020 VS 2024 VS 2031
1.3.2 Orthopedics & MSK
1.3.3 Aesthetics/Anti-Aging
1.3.4 Wound & Ulcer Care
1.3.5 Other
1.4 Market by Source of Material
1.4.1 Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material: 2020 VS 2024 VS 2031
1.4.2 Autologous
1.4.3 Allogeneic
1.4.4 Xenogeneic
1.5 Market by Application
1.5.1 Global Regenerative Biologic Injectables Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Biologic Injectables Market Perspective (2020-2031)
2.2 Global Regenerative Biologic Injectables Growth Trends by Region
2.2.1 Global Regenerative Biologic Injectables Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regenerative Biologic Injectables Historic Market Size by Region (2020-2025)
2.2.3 Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031)
2.3 Regenerative Biologic Injectables Market Dynamics
2.3.1 Regenerative Biologic Injectables Industry Trends
2.3.2 Regenerative Biologic Injectables Market Drivers
2.3.3 Regenerative Biologic Injectables Market Challenges
2.3.4 Regenerative Biologic Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Biologic Injectables Players by Revenue
3.1.1 Global Top Regenerative Biologic Injectables Players by Revenue (2020-2025)
3.1.2 Global Regenerative Biologic Injectables Revenue Market Share by Players (2020-2025)
3.2 Global Top Regenerative Biologic Injectables Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regenerative Biologic Injectables Revenue
3.4 Global Regenerative Biologic Injectables Market Concentration Ratio
3.4.1 Global Regenerative Biologic Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Biologic Injectables Revenue in 2024
3.5 Global Key Players of Regenerative Biologic Injectables Head office and Area Served
3.6 Global Key Players of Regenerative Biologic Injectables, Product and Application
3.7 Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Biologic Injectables Breakdown Data by Type
4.1 Global Regenerative Biologic Injectables Historic Market Size by Type (2020-2025)
4.2 Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031)
5 Regenerative Biologic Injectables Breakdown Data by Application
5.1 Global Regenerative Biologic Injectables Historic Market Size by Application (2020-2025)
5.2 Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regenerative Biologic Injectables Market Size (2020-2031)
6.2 North America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regenerative Biologic Injectables Market Size by Country (2020-2025)
6.4 North America Regenerative Biologic Injectables Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regenerative Biologic Injectables Market Size (2020-2031)
7.2 Europe Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regenerative Biologic Injectables Market Size by Country (2020-2025)
7.4 Europe Regenerative Biologic Injectables Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Biologic Injectables Market Size (2020-2031)
8.2 Asia-Pacific Regenerative Biologic Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025)
8.4 Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Regenerative Biologic Injectables Market Size (2020-2031)
9.2 Latin America Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025)
9.4 Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Biologic Injectables Market Size (2020-2031)
10.2 Middle East & Africa Regenerative Biologic Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025)
10.4 Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arthrex
11.1.1 Arthrex Company Details
11.1.2 Arthrex Business Overview
11.1.3 Arthrex Regenerative Biologic Injectables Introduction
11.1.4 Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.1.5 Arthrex Recent Development
11.2 Stryker
11.2.1 Stryker Company Details
11.2.2 Stryker Business Overview
11.2.3 Stryker Regenerative Biologic Injectables Introduction
11.2.4 Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.2.5 Stryker Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Biologic Injectables Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.3.5 Zimmer Biomet Recent Development
11.4 EmCyte
11.4.1 EmCyte Company Details
11.4.2 EmCyte Business Overview
11.4.3 EmCyte Regenerative Biologic Injectables Introduction
11.4.4 EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.4.5 EmCyte Recent Development
11.5 Regen Lab
11.5.1 Regen Lab Company Details
11.5.2 Regen Lab Business Overview
11.5.3 Regen Lab Regenerative Biologic Injectables Introduction
11.5.4 Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.5.5 Regen Lab Recent Development
11.6 Applied Biologics
11.6.1 Applied Biologics Company Details
11.6.2 Applied Biologics Business Overview
11.6.3 Applied Biologics Regenerative Biologic Injectables Introduction
11.6.4 Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.6.5 Applied Biologics Recent Development
11.7 Smith+Nephew
11.7.1 Smith+Nephew Company Details
11.7.2 Smith+Nephew Business Overview
11.7.3 Smith+Nephew Regenerative Biologic Injectables Introduction
11.7.4 Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.7.5 Smith+Nephew Recent Development
11.8 Organogenesis
11.8.1 Organogenesis Company Details
11.8.2 Organogenesis Business Overview
11.8.3 Organogenesis Regenerative Biologic Injectables Introduction
11.8.4 Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.8.5 Organogenesis Recent Development
11.9 MiMedx
11.9.1 MiMedx Company Details
11.9.2 MiMedx Business Overview
11.9.3 MiMedx Regenerative Biologic Injectables Introduction
11.9.4 MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.9.5 MiMedx Recent Development
11.10 Celularity
11.10.1 Celularity Company Details
11.10.2 Celularity Business Overview
11.10.3 Celularity Regenerative Biologic Injectables Introduction
11.10.4 Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025)
11.10.5 Celularity Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Regenerative Biologic Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Platelet-Rich Plasma (PRP)
Table 3. Key Players of Autologous Cell/BMAC/Stem-Cell Derived
Table 4. Key Players of Amniotic/Placental Allografts
Table 5. Key Players of Other
Table 6. Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Orthopedics & MSK
Table 8. Key Players of Aesthetics/Anti-Aging
Table 9. Key Players of Wound & Ulcer Care
Table 10. Key Players of Other
Table 11. Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Autologous
Table 13. Key Players of Allogeneic
Table 14. Key Players of Xenogeneic
Table 15. Global Regenerative Biologic Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Regenerative Biologic Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 18. Global Regenerative Biologic Injectables Market Share by Region (2020-2025)
Table 19. Global Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 20. Global Regenerative Biologic Injectables Market Share by Region (2026-2031)
Table 21. Regenerative Biologic Injectables Market Trends
Table 22. Regenerative Biologic Injectables Market Drivers
Table 23. Regenerative Biologic Injectables Market Challenges
Table 24. Regenerative Biologic Injectables Market Restraints
Table 25. Global Regenerative Biologic Injectables Revenue by Players (2020-2025) & (US$ Million)
Table 26. Global Regenerative Biologic Injectables Market Share by Players (2020-2025)
Table 27. Global Top Regenerative Biologic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Biologic Injectables as of 2024)
Table 28. Ranking of Global Top Regenerative Biologic Injectables Companies by Revenue (US$ Million) in 2024
Table 29. Global 5 Largest Players Market Share by Regenerative Biologic Injectables Revenue (CR5 and HHI) & (2020-2025)
Table 30. Global Key Players of Regenerative Biologic Injectables, Headquarters and Area Served
Table 31. Global Key Players of Regenerative Biologic Injectables, Product and Application
Table 32. Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Regenerative Biologic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 35. Global Regenerative Biologic Injectables Revenue Market Share by Type (2020-2025)
Table 36. Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 37. Global Regenerative Biologic Injectables Revenue Market Share by Type (2026-2031)
Table 38. Global Regenerative Biologic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 39. Global Regenerative Biologic Injectables Revenue Market Share by Application (2020-2025)
Table 40. Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 41. Global Regenerative Biologic Injectables Revenue Market Share by Application (2026-2031)
Table 42. North America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. North America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 44. North America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 45. Europe Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Europe Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 47. Europe Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 48. Asia-Pacific Regenerative Biologic Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 49. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031) & (US$ Million)
Table 51. Latin America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 53. Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 54. Middle East & Africa Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 56. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 57. Arthrex Company Details
Table 58. Arthrex Business Overview
Table 59. Arthrex Regenerative Biologic Injectables Product
Table 60. Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 61. Arthrex Recent Development
Table 62. Stryker Company Details
Table 63. Stryker Business Overview
Table 64. Stryker Regenerative Biologic Injectables Product
Table 65. Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 66. Stryker Recent Development
Table 67. Zimmer Biomet Company Details
Table 68. Zimmer Biomet Business Overview
Table 69. Zimmer Biomet Regenerative Biologic Injectables Product
Table 70. Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 71. Zimmer Biomet Recent Development
Table 72. EmCyte Company Details
Table 73. EmCyte Business Overview
Table 74. EmCyte Regenerative Biologic Injectables Product
Table 75. EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 76. EmCyte Recent Development
Table 77. Regen Lab Company Details
Table 78. Regen Lab Business Overview
Table 79. Regen Lab Regenerative Biologic Injectables Product
Table 80. Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 81. Regen Lab Recent Development
Table 82. Applied Biologics Company Details
Table 83. Applied Biologics Business Overview
Table 84. Applied Biologics Regenerative Biologic Injectables Product
Table 85. Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 86. Applied Biologics Recent Development
Table 87. Smith+Nephew Company Details
Table 88. Smith+Nephew Business Overview
Table 89. Smith+Nephew Regenerative Biologic Injectables Product
Table 90. Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 91. Smith+Nephew Recent Development
Table 92. Organogenesis Company Details
Table 93. Organogenesis Business Overview
Table 94. Organogenesis Regenerative Biologic Injectables Product
Table 95. Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 96. Organogenesis Recent Development
Table 97. MiMedx Company Details
Table 98. MiMedx Business Overview
Table 99. MiMedx Regenerative Biologic Injectables Product
Table 100. MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 101. MiMedx Recent Development
Table 102. Celularity Company Details
Table 103. Celularity Business Overview
Table 104. Celularity Regenerative Biologic Injectables Product
Table 105. Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 106. Celularity Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Regenerative Biologic Injectables Picture
Figure 2. Global Regenerative Biologic Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Regenerative Biologic Injectables Market Share by Type: 2024 VS 2031
Figure 4. Platelet-Rich Plasma (PRP) Features
Figure 5. Autologous Cell/BMAC/Stem-Cell Derived Features
Figure 6. Amniotic/Placental Allografts Features
Figure 7. Other Features
Figure 8. Global Regenerative Biologic Injectables Market Size Comparison by Therapeutic Application (2020-2031) & (US$ Million)
Figure 9. Orthopedics & MSK Features
Figure 10. Aesthetics/Anti-Aging Features
Figure 11. Wound & Ulcer Care Features
Figure 12. Other Features
Figure 13. Global Regenerative Biologic Injectables Market Size Comparison by Source of Material (2020-2031) & (US$ Million)
Figure 14. Autologous Features
Figure 15. Allogeneic Features
Figure 16. Xenogeneic Features
Figure 17. Global Regenerative Biologic Injectables Market Size by Application (2020-2031) & (US$ Million)
Figure 18. Global Regenerative Biologic Injectables Market Share by Application: 2024 VS 2031
Figure 19. Hospital Case Studies
Figure 20. Clinic Case Studies
Figure 21. Other Case Studies
Figure 22. Regenerative Biologic Injectables Report Years Considered
Figure 23. Global Regenerative Biologic Injectables Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Regenerative Biologic Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Regenerative Biologic Injectables Market Share by Region: 2024 VS 2031
Figure 26. Global Regenerative Biologic Injectables Market Share by Players in 2024
Figure 27. Global Regenerative Biologic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Regenerative Biologic Injectables Revenue in 2024
Figure 29. North America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 31. United States Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 35. Germany Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Regenerative Biologic Injectables Market Share by Region (2020-2031)
Figure 43. China Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 51. Mexico Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 55. Israel Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Arthrex Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 59. Stryker Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 60. Zimmer Biomet Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 61. EmCyte Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 62. Regen Lab Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 63. Applied Biologics Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 64. Smith+Nephew Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 65. Organogenesis Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 66. MiMedx Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 67. Celularity Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Regenerative Biologic Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Platelet-Rich Plasma (PRP)
Table 3. Key Players of Autologous Cell/BMAC/Stem-Cell Derived
Table 4. Key Players of Amniotic/Placental Allografts
Table 5. Key Players of Other
Table 6. Global Regenerative Biologic Injectables Market Size Growth Rate by Therapeutic Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Orthopedics & MSK
Table 8. Key Players of Aesthetics/Anti-Aging
Table 9. Key Players of Wound & Ulcer Care
Table 10. Key Players of Other
Table 11. Global Regenerative Biologic Injectables Market Size Growth Rate by Source of Material (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Autologous
Table 13. Key Players of Allogeneic
Table 14. Key Players of Xenogeneic
Table 15. Global Regenerative Biologic Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Regenerative Biologic Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 18. Global Regenerative Biologic Injectables Market Share by Region (2020-2025)
Table 19. Global Regenerative Biologic Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 20. Global Regenerative Biologic Injectables Market Share by Region (2026-2031)
Table 21. Regenerative Biologic Injectables Market Trends
Table 22. Regenerative Biologic Injectables Market Drivers
Table 23. Regenerative Biologic Injectables Market Challenges
Table 24. Regenerative Biologic Injectables Market Restraints
Table 25. Global Regenerative Biologic Injectables Revenue by Players (2020-2025) & (US$ Million)
Table 26. Global Regenerative Biologic Injectables Market Share by Players (2020-2025)
Table 27. Global Top Regenerative Biologic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Biologic Injectables as of 2024)
Table 28. Ranking of Global Top Regenerative Biologic Injectables Companies by Revenue (US$ Million) in 2024
Table 29. Global 5 Largest Players Market Share by Regenerative Biologic Injectables Revenue (CR5 and HHI) & (2020-2025)
Table 30. Global Key Players of Regenerative Biologic Injectables, Headquarters and Area Served
Table 31. Global Key Players of Regenerative Biologic Injectables, Product and Application
Table 32. Global Key Players of Regenerative Biologic Injectables, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Regenerative Biologic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 35. Global Regenerative Biologic Injectables Revenue Market Share by Type (2020-2025)
Table 36. Global Regenerative Biologic Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 37. Global Regenerative Biologic Injectables Revenue Market Share by Type (2026-2031)
Table 38. Global Regenerative Biologic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 39. Global Regenerative Biologic Injectables Revenue Market Share by Application (2020-2025)
Table 40. Global Regenerative Biologic Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 41. Global Regenerative Biologic Injectables Revenue Market Share by Application (2026-2031)
Table 42. North America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. North America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 44. North America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 45. Europe Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Europe Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 47. Europe Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 48. Asia-Pacific Regenerative Biologic Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 49. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Regenerative Biologic Injectables Market Size by Region (2026-2031) & (US$ Million)
Table 51. Latin America Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Latin America Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 53. Latin America Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 54. Middle East & Africa Regenerative Biologic Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 56. Middle East & Africa Regenerative Biologic Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 57. Arthrex Company Details
Table 58. Arthrex Business Overview
Table 59. Arthrex Regenerative Biologic Injectables Product
Table 60. Arthrex Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 61. Arthrex Recent Development
Table 62. Stryker Company Details
Table 63. Stryker Business Overview
Table 64. Stryker Regenerative Biologic Injectables Product
Table 65. Stryker Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 66. Stryker Recent Development
Table 67. Zimmer Biomet Company Details
Table 68. Zimmer Biomet Business Overview
Table 69. Zimmer Biomet Regenerative Biologic Injectables Product
Table 70. Zimmer Biomet Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 71. Zimmer Biomet Recent Development
Table 72. EmCyte Company Details
Table 73. EmCyte Business Overview
Table 74. EmCyte Regenerative Biologic Injectables Product
Table 75. EmCyte Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 76. EmCyte Recent Development
Table 77. Regen Lab Company Details
Table 78. Regen Lab Business Overview
Table 79. Regen Lab Regenerative Biologic Injectables Product
Table 80. Regen Lab Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 81. Regen Lab Recent Development
Table 82. Applied Biologics Company Details
Table 83. Applied Biologics Business Overview
Table 84. Applied Biologics Regenerative Biologic Injectables Product
Table 85. Applied Biologics Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 86. Applied Biologics Recent Development
Table 87. Smith+Nephew Company Details
Table 88. Smith+Nephew Business Overview
Table 89. Smith+Nephew Regenerative Biologic Injectables Product
Table 90. Smith+Nephew Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 91. Smith+Nephew Recent Development
Table 92. Organogenesis Company Details
Table 93. Organogenesis Business Overview
Table 94. Organogenesis Regenerative Biologic Injectables Product
Table 95. Organogenesis Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 96. Organogenesis Recent Development
Table 97. MiMedx Company Details
Table 98. MiMedx Business Overview
Table 99. MiMedx Regenerative Biologic Injectables Product
Table 100. MiMedx Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 101. MiMedx Recent Development
Table 102. Celularity Company Details
Table 103. Celularity Business Overview
Table 104. Celularity Regenerative Biologic Injectables Product
Table 105. Celularity Revenue in Regenerative Biologic Injectables Business (2020-2025) & (US$ Million)
Table 106. Celularity Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Regenerative Biologic Injectables Picture
Figure 2. Global Regenerative Biologic Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Regenerative Biologic Injectables Market Share by Type: 2024 VS 2031
Figure 4. Platelet-Rich Plasma (PRP) Features
Figure 5. Autologous Cell/BMAC/Stem-Cell Derived Features
Figure 6. Amniotic/Placental Allografts Features
Figure 7. Other Features
Figure 8. Global Regenerative Biologic Injectables Market Size Comparison by Therapeutic Application (2020-2031) & (US$ Million)
Figure 9. Orthopedics & MSK Features
Figure 10. Aesthetics/Anti-Aging Features
Figure 11. Wound & Ulcer Care Features
Figure 12. Other Features
Figure 13. Global Regenerative Biologic Injectables Market Size Comparison by Source of Material (2020-2031) & (US$ Million)
Figure 14. Autologous Features
Figure 15. Allogeneic Features
Figure 16. Xenogeneic Features
Figure 17. Global Regenerative Biologic Injectables Market Size by Application (2020-2031) & (US$ Million)
Figure 18. Global Regenerative Biologic Injectables Market Share by Application: 2024 VS 2031
Figure 19. Hospital Case Studies
Figure 20. Clinic Case Studies
Figure 21. Other Case Studies
Figure 22. Regenerative Biologic Injectables Report Years Considered
Figure 23. Global Regenerative Biologic Injectables Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Regenerative Biologic Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Regenerative Biologic Injectables Market Share by Region: 2024 VS 2031
Figure 26. Global Regenerative Biologic Injectables Market Share by Players in 2024
Figure 27. Global Regenerative Biologic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Regenerative Biologic Injectables Revenue in 2024
Figure 29. North America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 31. United States Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 35. Germany Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Regenerative Biologic Injectables Market Share by Region (2020-2031)
Figure 43. China Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 51. Mexico Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Regenerative Biologic Injectables Market Share by Country (2020-2031)
Figure 55. Israel Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Regenerative Biologic Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Arthrex Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 59. Stryker Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 60. Zimmer Biomet Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 61. EmCyte Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 62. Regen Lab Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 63. Applied Biologics Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 64. Smith+Nephew Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 65. Organogenesis Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 66. MiMedx Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 67. Celularity Revenue Growth Rate in Regenerative Biologic Injectables Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232